Philosophy & Program Principals

At StarLux, our breeding philosophy aligns with longstanding principles of responsible stewardship of the Border Collie breed. The Border Collie Society of America’s Code of Ethics emphasizes that every decision should support the best interests of the breed, including improving health, soundness, temperament, and intelligence. Breeders are encouraged to act with integrity, transparency, and respect for the dogs, the breed, and other breeders.

We share these principles. Each breeding at StarLux is evaluated with respect to structure, movement, temperament, and long‑term soundness. We breed with intention, choosing pairings that are compatible and complementary, and we document matings responsibly. Our decisions are informed by careful observation and mentorship rather than short‑term goals or convenience.

Clear communication with those who trust us with their future dogs is fundamental. We provide accurate health information, honest expectations, and support throughout a dog’s life. We continue to learn and improve, drawing on breed standards, ethical guidelines, and shared knowledge in the Border Collie community.

To play, press and hold the enter key. To stop, release the enter key.

Health & Genetic Testing —
Detailed Explanation

Health testing and genetic evaluation are foundational to the StarLux breeding program. While Border Collies are generally considered a healthy breed, no purebred canine is free from the risk of heritable conditions. Responsible breeders use health screening and genetic testing to inform pairing decisions and reduce disease risk, rather than simply hoping for healthy outcomes.

Why Testing Matters

The goal of health testing is to identify inherited conditions before they affect offspring. Some conditions are highly heritable, meaning genetic variants directly increase disease risk. Others are more complex, influenced by multiple genes and environmental factors. By conducting appropriate evaluations, breeders can make informed decisions that support the long‑term health and functionality of the breed.

Core Structural and Performance Evaluations

•Hip and Elbow Evaluation: X‑rays assessed by OFA (Orthopedic Foundation for Animals) or equivalent ensure skeletal soundness and help reduce the incidence of dysplasia.

•Certified Eye Examinations: Annual checks by a board‑certified veterinary ophthalmologist help detect conditions affecting ocular health.

Breed‑Specific Genetic Tests

Breed clubs and health foundations recommend genetic tests that identify carriers or affected dogs for specific conditions. These tests are essential tools for breeders to help reduce risk and preserve genetic diversity.

•Collie Eye Anomaly (CEA): A congenital condition affecting retina development. Genetic testing can determine whether a dog is clear, a carrier, or affected, helping inform pairing decisions so affected puppies are not produced.

•Multidrug Sensitivity (MDR1/ABCB1): Mutation in this gene affects how dogs process certain medications. Knowing a dog’s status helps veterinarians adjust drug protocols and breeders avoid producing dogs with serious drug sensitivities.

•Progressive Retinal Atrophy (PRA) and other retinal conditions: Though rare in Border Collies, testing for PRA and other retinal disorders can help avoid introducing or perpetuating vision‑impairing mutations.

•Complex Genetic Conditions (e.g., Border Collie Collapse): Some disorders have moderately high heritability and involve multiple genetic influences. Research continues to improve understanding and testing for these conditions.

Border Collie Glaucoma (BCG) — Key Facts

What it is:

• A heritable form of glaucoma seen in some Border Collies.

Testing:

• GenSol: Standalone marker test; correlates with BCG but the causative gene is not yet confirmed.

• Optimal Selection (OS): Previously offered BCG testing, now discontinued due to inconsistent results. Some results were accurate, especially distinguishing affected dogs from normal.

• Animal Genetics: Offers a standalone BCG marker test.

• Embark: Provides a general glaucoma test, not accurate for Border Collies.

Why test:

• Early marker testing helps reduce risk.

• Every tested dog contributes data, moving research closer to a definitive gene test.

• Multiple labs/tests can help confirm results.

Limitations:

• Tests are not 100% predictive.

• Results should be considered along with pedigree, clinical observation, and other health screenings.

Breeder Takeaway: Testing is a proactive step. While still evolving, using BCG marker tests responsibly helps protect the breed and informs future breeding decisions. The causative gene(s) have not been identified, this test should be used as a guide along with pedigree knowledge in my opinion.

How We Use the Results

At StarLux, results from genetic tests and structural evaluations are not simply checkboxes. They are integrated into a broader assessment of each dog’s strengths and limitations. When planning a breeding, we consider how test results align with phenotype (observable traits), temperament, and performance outcomes. Dogs may be “clear” for certain genetic conditions yet still require evaluation of movement, behavior, and overall soundness before placement in a breeding program.

Ongoing Monitoring

Genetic and health testing is an ongoing commitment. Some conditions may only become apparent with age or through cumulative screening over multiple generations. We maintain thorough records, update clearances as new tests become available, and share relevant results with owners, prospective owners, and, where appropriate, health databases such as OFA and CHIC.